Matrix stiffness 2026-10-20
Matrix stiffness describes resistance of an extracellular matrix to deformation under a specified loading geometry and timescale. It differs from pore size, ligand density and fibre alignment, although changing a matrix formulation can alter all of them.
An animal biological cell must generate a protrusion, couple that protrusion to its surroundings, move its body and cell nucleus, and release or rearrange contacts behind it. Cell polarity makes these events persistent in one direction. At cellular scales, inertia is usually negligible: active forces balance resistance continuously, rather than giving the cell momentum that carries it forward after propulsion stops. ATP consumption maintains the system away from thermodynamic equilibrium.
At the front, actin polymerization can push the cell membrane into a lamellipodium. Whether this produces advance depends on coupling to the environment: without a mechanical grip, the actin network can move backward instead. On a flat adhesive substrate, integrins bind the extracellular matrix and connect through focal adhesions to the cytoskeleton. Regulated engagement transmits traction, while rearward myosin contraction and adhesion turnover move the rest of the cell. Adhesions must resist slipping long enough to transmit force but release to avoid anchoring the rear indefinitely. Another protrusive mechanism is a membrane bleb: local separation of the cell membrane from the cell cortex, driven by intracellular pressure, expands the membrane before a new cortex assembles underneath it.
A two-dimensional culture surface offers a broad basal contact area and little geometrical obstruction above the cell. A three-dimensional environment adds pore size, fibre orientation, matrix stiffness, and resistance from surrounding cells. The same cells may switch between elongated, strongly adhesive migration and more rounded, weakly adhesive movement. Proteolysis can enlarge a path through the extracellular matrix, but a sufficiently permissive existing pore need not require digestion. The relatively stiff cell nucleus can become the main bottleneck; its passage depends on deformation, confinement and force transmission. Extensive squeezing can damage the nuclear envelope, so migration speed alone is not a sufficient measure of successful transit.
A decisive experiment removed all functional integrins from mouse leukocytes. Their interstitial migration in three-dimensional environments persisted, and myosin became particularly important for passage through narrow gaps. This distinguishes force generation from a particular adhesion mechanism: confinement and friction can provide useful coupling even without integrin anchoring.[ref]
Thus “three-dimensional migration requires stronger adhesion” is not a general rule. A useful comparison holds ligand density, matrix stiffness and pore geometry as independently controlled as possible, measures whole-cell and nuclear movement, and perturbs actin, myosin, integrins and matrix digestion separately. Differences then identify which mechanical requirement has changed, rather than treating dimensionality as a single unexplained variable.
A good in-vitro model should distinguish cancer invasion, movement across a tissue boundary into surrounding material, from simple growth or movement across a flat surface. No single assay reproduces the entire sequence from a primary tumour to a distant metastasis. Choose the assay to answer a specified mechanistic question, then confirm the result in a model that retains additional biological constraints.
A scratch assay measures closure of a gap in a monolayer. It is inexpensive and permits live-cell imaging, but closure combines cell migration, spreading and cell proliferation, and the wound releases signals and damages cells. It does not by itself demonstrate invasion through a basement membrane. A porous-membrane assay can measure transit toward a stimulus; adding an extracellular barrier tests an additional requirement. Yet pore size, coating thickness, chemical gradients and the counting time can dominate the result, and endpoint cell counts hide whether treatment altered survival or actual migration.
Three-dimensional tumour spheroids or organoids embedded in a defined extracellular matrix allow individual and collective invasion to be followed over time. Quantify invasion distance, cell escape, strand architecture and leader-follower behaviour, alongside changes in spheroid size and viability. Use collagen-rich and basement-membrane-like environments to test whether a phenotype depends on matrix identity. Independently vary ligand presentation, matrix stiffness and pore dimensions where possible: increasing collagen concentration changes several of them simultaneously.
A primary study of breast tumour organoids identified invasive leader cells expressing a basal epithelial programme, including K14 and p63; reducing either component impaired collective invasion in that system. The experiment connected a defined cellular subpopulation to an invasion phenotype rather than assuming that every tumour cell was equivalent.[ref] Its conclusion remains specific to the tested settings and does not make these markers universal requirements for invasion.
Add stromal cells, immune cells or a vessel-like boundary if the question concerns their interactions. Microfluidics can impose controlled gradients and permit live-cell imaging of entry into or exit from a channel. Include non-invasive and invasive controls, perturbation controls, rescue where feasible, and matched measurements of cell proliferation and death. Follow individual cells rather than relying solely on a final stained area. Patient-derived material should include multiple independent tumours: many fields from one culture are not independent patient replicates.
Limitations remain substantial. Culture selects cells that tolerate the medium; long-passaged lines may lose the original tumour's diversity. Matrices and added growth factors can have variable composition. Isolated cultures omit native immune surveillance, vascular perfusion, whole-organ architecture and systemic influences. Even elaborate organoids incompletely reproduce these features. Finally, invasion is only one stage: it does not establish survival in blood, colonization of a distant organ, or clinical response. Agreement across complementary assays strengthens a mechanism; no dish-based result alone proves a metastatic outcome in a person.